genuine question about regulatory that I am slightly embarrassed to ask
Quick one. Canada here. tendon works very differently where I live than in the threads that dominate the front page, and I keep seeing people confidently given advice that simply does not apply outside the US. Specifics: the route I used took 3 weeks and cost roughly what I expected. The admin was worse than the…
rodent data must be labelled as rodent data
Stalled for 10 weeks, changed nothing, and it started moving again on week 71.
sequence and naming claims need the actual sequence
research use only, no human protocols, no injection instructions
research use only, no human protocols, no injection instructions
Adding to this: regulatory is doing more work than the comment implies.
BPC pentadecapeptide is a naming problem, three things are called this
What are you comparing it against though?
the sequence variation is the real issue
Yeah, rodent data does not scale to humans.
This is the "correlation is mechanism" thing again. You changed three variables at once.
sequence and naming claims need the actual sequence
sequence and naming claims need the actual sequence
Yes, exactly this, and it is the bit that took me 58 weeks to accept.
regulatory status changed in 15 countries, check yours
handlers in the community are rare and cautious